Antibody-mediated rejection of the kidney after simultaneous pancreas-kidney transplantation.
The prevalence, risk factors, and outcome of antibody-mediated rejection (AMR) of the kidney after simultaneous pancreas-kidney transplantation are unknown. In 136 simultaneous pancreas-kidney recipients who were followed for an average of 3.1 yr, 21 episodes of AMR of the kidney allograft were identified. Eight episodes occurred early (
Pascual, J; Samaniego, MD; Torrealba, JR; Odorico, JS; Djamali, A; Becker, YT; Voss, B; Leverson, GE; Knechtle, SJ; Sollinger, HW; Pirsch, JD
Volume / Issue
Start / End Page
Pubmed Central ID
Electronic International Standard Serial Number (EISSN)
Digital Object Identifier (DOI)